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Introduction
Intravenous (IV) catheter placement is the most frequently performed hospital procedure.1 IV
catheters are essential for administering medications, fluids, radiographic contrast media, and collecting
blood specimens.2,3 However, IV catheter placement can be problematic in patients with veins that are not
palpable or visible as this may delay the course of treatment. Most studies define difficult venous access
as undergoing at least two IV attempts without success or use of other methods of IV placement.4
Alternative means of IV access include the use of an atypical vein (i.e., external jugular vein), ultrasoundguided peripheral intravenous catheter (USGPIV) placement, intraosseous (IO) device use, or central
venous catheter (CVC) placement. Current literature suggests that chronic medical conditions, IV drug
abuse, chemotherapy, sickle cell disease, obesity, and dialysis may be contributing factors to difficulty
obtaining IV access.4
Central venous access is a standard method of obtaining vascular access in the Emergency
Department (ED) and the Intensive Care Unit (ICU). As many as 5,000,000 CVCs are placed in the
United States per year, most often in patients with a high severity of illness.5 Central venous monitoring,
vasoactive medications, centrally administered medications, total parental nutrition, hemodialysis, and
renal replacement therapy are indications for central venous access.6 However, in patients with difficult
venous access, CVC placement is utilized as a rescue method of IV access when peripheral IV catheter
insertion attempts are unsuccessful. CVC insertion is an invasive procedure which most commonly
utilizes the subclavian, femoral, and internal jugular veins for access. Furthermore, CVC placement is a
time-consuming procedure, requiring sterile precautions, and a chest x-ray to confirm placement due to a
40% incidence of mispositioning.7,8 Although an effective means of vascular access, CVC placement is
associated with a greater than 15% complication rate, including pneumothorax, hematoma formation, air
embolism, arterial puncture, arrhythmias, vessel damage, thrombosis, and central line associated
bloodstream infections.3,4,8,9 Additionally, CVC complications and associated bloodstream infections lead
to increased healthcare costs, extended hospital length of stay, and a source of morbidity for patients. 5
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In order to minimize CVC complication rates, the utilization of USGPIVs may be a promising
replacement for CVC insertion in patients with difficult IV access.5 Performed by a variety of healthcare
professionals, bedside ultrasound provides visualization of deeper peripheral vessels that are not
discernible by physical examination and allows for the guidance of IV catheter cannulation.4,8
Complications associated with USGPIV cannulation are similar to those of traditional peripheral IV
insertion techniques, including infiltration, arterial puncture, thrombosis, and contact with adjacent
nerves.10 In comparison to traditional landmark techniques, USGPIV appears to be an effective means of
vascular access. In a study performed by Keyes et al., USGPIV placement was associated with a 91%
success rate in 101 ED patients. Additionally, the study found the average USGPIV procedure length to
be 77 seconds.11 In a comparison of USGPIV to traditional landmark techniques in patients with difficult
intravenous access performed by Constantino et al., there was a success rate of 97% for the USGPIV
group and a reduction in overall time to cannulation compared to the traditional landmark approach.2
USGPIV insertion is also associated with higher patient satisfaction in comparison to the traditional
landmark approaches in difficult IV access patients.2,12
This paper aims to evaluate the evidence from the literature for the use of USGPIV access in the
reduction of CVC placement during a patient’s hospital stay.
Does USGPIV insertion reduce CVC placement rates?
A retrospective cohort study performed at an urban academic ED using time-series analysis
revealed a reduction in CVC placement rates during the implementation of a USGPIV program. During
the six-year study, the ED saw 401,532 patients, of whom 1,583 (0.39%) received CVC catheters. The
study demonstrated an 80% reduction in CVC rates from 0.81% to 0.16% and revealed that the reduction
in CVC placement was more significant among noncritically ill patients, including floor patients,
telemetry patients, and discharged patients compared to critically ill patients. Furthermore, there were no
CVCs placed in patients discharged from the ED in the final year of the study. However, the proportion of
CVC placement in the critically ill population compared to the noncritically ill population increased from
34% to 81% because there was an overall reduction in the number of CVCs placed in the noncritically ill
2

patients.5 These findings highlighted that USGPIV use reduces the number of CVCs placed in
noncritically ill patients.
Given the increased frequency in CVC placement among patients with difficult intravenous
access, a study was conducted to determine the reduction in CVC placement due to USGPIVs in the
difficult IV access population. In this prospective, observational study conducted in an urban ED, patients
with at least two failed peripheral IV attempts, inability to palpate peripheral veins on physical
examination or inability to secure external jugular access were enrolled and underwent USGPIV
placement. The study followed the enrolled patients to evaluate for CVC placement and related
complications for up to seven days. One hundred patients underwent USGPIV placement with 12
USGPIV failures before ED disposition, of which four required CVC placement. Of the 88 patients with
functional USGPIVs in the ED, 72 were admitted, 1 CVC was placed, and 10 PICC lines were required.
The study demonstrated an 85% reduction in CVC placement due to USGPIV implementation in difficult
IV access patients. This study indicates that USGPIVs may be an effective alternative to CVCs in
reducing morbidity in these patients.8
Do USGPIVs have a role in the inpatient setting?
The implementation of USGPIVs to reduce CVC placement has been studied primarily in the ED
setting. A retrospective cohort review performed by Gregg et al. analyzed the use of USGPIV in adult
patients admitted to a surgical ICU (cardiac, trauma, or neurotrauma) who did not indicate a need for
CVC requirement. The study reported that there were 77 provider requests for USGPIV placement in 59
ICU patients whose peripheral IV access could not be obtained through traditional techniques. The
inability to obtain peripheral intravenous access included edema (95%), obesity (42%), history of IV drug
use (8%), and need for emergency access (4%). The study reported a total of 148 peripheral intravenous
lines (PIV) requested with 147 PIV successfully placed.6 Furthermore, the discontinuation of 40 central
lines and avoidance of 34 CVCs was reported as a result of placing a PIV, revealing that the
implementation of USGPIV insertion reduced unnecessary CVC placement in the ICU setting.6
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In addition to the ICU, a cohort study in an inpatient medical unit evaluated the effect of the
implementation of USGPIV to reduce CVC placement. The study revealed a reduction in the rate of
CVCs placed in the USGPIV intervention unit (mean 0.47) compared to the control unit (mean 0.67);
however, the difference was not statically significant with a P=0.08. Due to the statistical insignificance,
further studies are needed to evaluate the use of USGPIVs in the reduction of central lines on an inpatient
medical floor.3
How long do USGPIVs last?
As evidenced by the studies above, the use of USGPIVs allows for a reduction in CVC placement
in difficult IV access patients. However, there is limited information about the efficacy of USGPIVs
continued use over an extended period of time. A prospective observational study performed by Dargin et
al. evaluated the survival of USGPIVs beyond the ED. The study enrolled 75 patients and found the
median USGPIV survival to be 26 hours, with a 56% survival rate across all settings. In the ED, 47% of
the USGPIVs failed within 24 hours, mostly due to infiltration. Only five patients underwent CVC
placement, although 63% of operators reported that a CVC would have been necessary without the initial
USGPIV access. Additionally, after USGPIV failure, only one central line was placed, and there were no
thrombotic or infectious complications.9 Although the study was statistically significant, selection bias
may have occurred due to potentially eligible patients not enrolled in the study or documentation error.
The results of this study indicate that USGPIV placement is an effective means of establishing IV access
and reduces the need for more invasive CVC placement in stable ED patients. However, USGPIVs are
associated with shorter indwelling times, which is most frequently due to infiltration or dislocation.9
Although USGPIV placement is associated with a high failure rate, limited research has been
completed to reveal the number of patients who go on to require CVC insertion after USGPIV failure. A
retrospective cohort analysis concluded that 43 of 343 (13.1%) patients required CVC placement after
USGPIV failure. The study also analyzed the correlation between risk factors for difficult venous access,
including diabetes, IV drug abuse, peripheral vascular disease, end-stage renal disease, sickle cell disease
and the risk of subsequent CVC placement after USGPIV failure.1 None of the risk factors associated
4

with difficult IV access analyzed were predictive of CVC placement. The findings suggested that length
of stay and admission to a higher level of care (ICU or step down unit) were the only predictive factors
associated with subsequent CVC insertion.1 While approximately one in eight patients with difficult IV
access required subsequent CVCs after admission from the ED with a USGPIV, there was ultimately a
reduction in the number of CVCs placed. This result supports the findings that USGPIVs can reduce the
number of CVCs placed in difficult IV access patients. Even with the reduction in central line placement,
approximately 13% of difficult IV access patients receiving USGPIVs in the ED will go on to require a
CVC due to USGPIV failure or the need for more central access for a higher level of care.1
Discussion
Evidence reveals that USGPIV insertion reduces the frequency of CVC placement in difficult IV
access patients in the ED setting, particularly in noncritically ill patients. The use of USGPIVs in place of
central lines has the potential to reduce cannulation time and increase patient satisfaction upon initial
insertion. Furthermore, the significance of these studies indicates a potential reduction in morbidity,
healthcare costs, and extended length of hospital stay due to the reduction of CVC complications.
The current literature does not provide sufficient evidence to conclude that USGPIV insertion
reduces the number of CVCs placed outside of the ED. The study performed by Gregg et al. demonstrated
a reduction in CVC placement with the use of USGPIV in patients that did not require central venous
access in the ICU.6 While the study indicates a possible reduction in CVCs, there is not another study that
analyzes the use of USGPIV to reduce central lines in the ICU setting. The study performed by Galen et
al. indicates there may be a reduction in CVCs due to USGPIV placement in the inpatient setting;
however, the research was not statistically significant.3 Further research is required to evaluate the use of
USGPIVs to reduce the number of CVCs placed outside of the ED to identify and quantify the benefits
associated with a reduction in CVC placement throughout a patient’s hospital stay.
Although the literature demonstrates success in the reduction of CVC insertion due to the
implementation of USGPIVs in the ED setting, the evidence denotes that USGPIVs have a high failure
rate beyond the ED. While the occurrence is relatively low, difficult IV access patients who received an
5

USGPIV in the ED setting may go on to require a CVC. Further research is necessary to investigate the
repercussions associated with premature USGPIV failure and the need for subsequent CVC insertion.
The current research does not provide enough evidence to support the use of USGPIV access over
CVC placement during a patient’s hospital stay as the standard of practice. Without further research,
USGPIVs may be used to reduce CVC placement among patients in the ED. Beyond the patient’s stay in
the ED, the decision to utilize USGPIVs in difficult IV access patients remains at the discretion of the
provider. The provider should consider the patient’s disposition, length of stay, and comorbidities to aid
their decision-making process. Until further studies are conducted, the use of USGPIVs in difficult IV
access patients remains a potential source of reduced complications, length of hospital stay, and
healthcare costs.
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